In the pharmaceutical industry, large-scale research and innovation have been broadly recognized as the major drivers of performance. While this paradigm is still valid, owing to the need to increase firms dimension in order to cope with the high risks related with innovation processes, it would...

There is a wide consensus among scholars of the pharmaceutical sector that the American pharmaceutical sector has been much more dynamic and successful than the European one from the mid-1990s onward. The aim of this paper is to reconsider the statistical limelights commonly adopted to justify...

Health care markets are typical examples of market failure, leading to relevant public regulation. In the last decade, the sector was widely reformed in many countries due to a growth of health care expenditure overwhelming economic growth. A common feature of the reforming process is the...

With aim of providing useful policy suggestion, it seems advisable to keep under consideration the assumptions underlying the Health Industry Model-HIM (Di Tommaso, Schweitzer 2000). This paper aims at providing useful information to gain an insight into a few typical behaviors of businesses in...

The recent evolution of Italian capitalism shows the increasing relevance of medium-sized enterprises (MSE) at three levels: the economic and institutional environment, the ownership structure and the financing policy. A comparison of the financial structure of Italian MSEs with some European...